Evidence map›Paper›PMID 40342805›Full record

ArticleThe annals of applied statistics2023

An extension of estimating equations to model longitudinal medical cost trajectory with Medicare claims data linked to SEER cancer registry.

Shikun Wang, Jing Ning, Ying Xu, Ya-Chen Tina Shih, Y U Shen, Liang Li

Abstract read
In one paragraph

Article in The annals of applied statistics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shikun WangDepartment of Biostatistics, The University of Texas MD Anderson Cancer Center.
Jing NingDepartment of Biostatistics, The University of Texas MD Anderson Cancer Center.
Ying XuDepartment of Health Services Research, The University of Texas MD Anderson Cancer Center.
Ya-Chen Tina ShihDepartment of Health Services Research, The University of Texas MD Anderson Cancer Center.
Y U ShenDepartment of Biostatistics, The University of Texas MD Anderson Cancer Center.
Liang LiDepartment of Biostatistics, The University of Texas MD Anderson Cancer Center.

Funding

Estimating the Cost Trajectories and Projecting the Cost of Cancer Care in the United States: Methodology and ApplicationR01CA225646 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI LI, LIANG, SHIH, YA-CHEN TINA · 2018 to 2022
$1.8M
NCI NIH HHS R01 CA225646
6 · The paper itself

Abstract

Insurance claims data is an increasingly important health policy research resource, given its longitudinal assessment of cancer care clinical outcomes. Population-level information on medical cost trajectory from disease diagnosis to terminal events, such as death, specifically interests policy makers. Estimating the mean cost trajectory has statistical challenges. The shape of the trajectory is usually highly nonlinear with varying durations, depending on the diagnosis-to-death population time distribution. The terminal event may be right censored, resulting in missing subsequent costs. Medical costs often have skewed distributions with zero-inflation and heteroscedasticity, which may not fit well with the commonly used parametric family of distributions. In this paper, we propose a flexible semi-parametric model to address challenges without imposing a cost data distributional assumption. The estimation procedure is based on generalized estimating equations with censored covariates. The proposed model adopts a bivariate surface that quantifies the interrelationship between longitudinal medical costs and survival, and results in the nonlinear population mean cost trajectory conditional on the death time. We develop a novel generalized estimating equations algorithm to accommodate covariates subject to right-censoring, without fully specifying the joint distribution of the cost and survival data. We provide theoretical and simulation-based justification for the proposed approach, and apply the methods to estimate prostate cancer patient cost trajectories from the Surveillance, Epidemiology, and End Results (SEER)-Medicare linked database.

Indexed as

Bivariate penalized splineGeneralized estimating equationsJoint modelingMedical costSEER-Medicare

Identifiers

PMID40342805
PMCPMC12061044

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.